Profile: West Pharmaceutical Services Inc (WST)
13 Mar 2014
West Pharmaceutical Services, Inc. (West), incorporated on July 27, 1923, is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Its business operations are organized into two segments: Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services. Its customers include the global producers and distributors of pharmaceuticals, biologics, medical devices and personal care products.
Packaging Systems Segment
Its Packaging Systems segment develops, manufactures and sells primary packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. The growth strategy for Packaging Systems includes organic growth through market segmentation, new product innovation, strategic acquisitions and geographic expansion. The Company has manufacturing facilities in North and South America, Europe and Asia, with affiliated companies in Mexico and Japan. Its Packaging Systems segment consists of three operating segments: Americas, Europe and Asia Pacific.
Packaging Systems' products consist of elastomeric components offered in a variety of standard and customer-specific configurations and formulations, which are available with advanced barrier films and coatings to enhance their performance. West FluroTec barrier film is applied using a patented molding process to reduce the risk of product loss by contamination and protect the shelf life of packaged drugs. The Company also applies a Teflon coating to the surface of stoppers and plungers to improve compatibility between the closure and the drug. B2-coating is a coating applied to the surface of stoppers and plungers using a patented process that eliminates the need for conventional silicone application. It helps manufacturers reduce product rejections due to trace levels of silicone molecules found in non-coated packaged drug compounds. FluroTec and B2-coating technologies are licensed from Daikyo Seiko, Ltd.
In addition, its Westar RS and Westar RU post-manufacturing processes are documented and fully validated procedures for washing and siliconizing stoppers and syringe components to remove biological materials and endotoxins. The Westar RS process prepares components for introduction into the customer's sterilizer and the Westar RU process provides sterilized components. These processes increase the overall efficiency of injectable drug production by outsourcing component processing, thereby eliminating steps otherwise required in each of its customers' manufacturing processes, and help to assure compliance with the latest regulatory requirements for component preparation. The Company also offers Envision components that are inspected using automated vision inspection systems, ensuring that components (plungers and stoppers) meet enhanced specifications for visible and sub visible particulate and contamination.
The Company’s recently introduced NovaPure components, which include serum and lyophilization stoppers and syringe plungers, incorporate by design principles and are manufactured utilizing advanced process technologies. Its tamper-evident Flip-Off seals are sold in a wide range of sizes and colors to meet customers' needs for product identification and differentiation. The seals can be provided using printing for cautionary statements and embossing technology that can serve as a counterfeiting deterrence.
The Company offers contract analytical laboratory services for testing and evaluating primary drug-packaging components and their compatibility with the contained drug formulation. West Analytical Services provides the Company and its customers with the knowledge and analysis of the interaction and compatibility of drug products with elastomer, glass and plastic packaging components. Its analytical laboratories also provide specialized testing for complete drug delivery systems.
Delivery Systems Segment
Its Delivery Systems segment develops, manufactures and sells safety and administration systems, multi-component systems for drug administration and a variety of custom contract-manufacturing solutions targeted to the healthcare and consumer-products industries. Delivery Systems has Specialists in product design and development, including in-house mold design and construction, an engineering center for developmental and prototype tooling, process design and validation and high-speed automated assemblies. In addition, Delivery Systems is responsible for the continued development and commercialization of its line of healthcare, administrative and advanced injection systems, including Daikyo CZ, SmartDose and other systems. Delivery Systems have manufacturing operations in North America and Europe.
The Company offers customer contract-manufacturing and assembly solutions, which use such technologies as multi-component molding, in-mold labeling, ultrasonic welding and clean room molding and device assembly used to manufacture customer-owned components and devices used in surgical, diagnostic, ophthalmic, other drug delivery systems, personal care and consumer products. Its administration systems include sterile devices for the administration of drug products, including patented products such as the MixJect transfer device, the Mix2Vial needleless reconstitution system and vial adapters.
The Daikyo CZ 1ml long Insert Needle syringe system is the syringe system without silicone oil lubrication applied to the barrel or plunger and that incorporates an insert-molded needle to avoid the need for adhesive. The luer lock version of the Daikyo CZ syringe system was introduced previously, along with several sizes of sterile vials. Additional sizes of vials continue to be introduced. CZ technology is licensed from Daikyo Seiko, Ltd. The ConfiDose and SelfDose auto-injector systems enhance patient compliance and safety. The needle remains shielded at all times and retracts automatically after the injection. These systems eliminate preparation steps and automate the injection of drugs, providing patients with a sterile, single-use disposable system that can be readily used at home.
West Pharmaceutical Services Inc
101 GORDON DR,
P O Box 645
LIONVILLE PA 19341-0645